SLS — Sellas Life Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Sellas Life Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	35.3	21.4	17.1	2.53	13.9
Net Total Accounts Receivable
Net Total Receivables	1.13	0	—	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	36.9	23	17.8	3.17	16.3
Net Property, Plant And Equipment	0.896	0.723	0.874	0.858	0.925
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	46	26.3	20.9	6.22	19.4
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	12.3	4.98	15.5	13.7	9.51
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	18.1	5.93	16.1	14.2	9.97
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	28	20.3	4.85	-7.98	9.46
Total Liabilities & Shareholders' Equity	46	26.3	20.9	6.22	19.4
Total Common Shares Outstanding